189 related articles for article (PubMed ID: 16265341)
1. Cell therapy for cardiovascular disease: what cells, what diseases and for whom?
Caplice NM; Gersh BJ; Alegria JR
Nat Clin Pract Cardiovasc Med; 2005 Jan; 2(1):37-43. PubMed ID: 16265341
[TBL] [Abstract][Full Text] [Related]
2. Endothelial progenitor cells: new perspectives and applications in cardiovascular therapies.
Marsboom G; Janssens S
Expert Rev Cardiovasc Ther; 2008 Jun; 6(5):687-701. PubMed ID: 18510485
[TBL] [Abstract][Full Text] [Related]
3. Clinical trials in stem cell therapy: pitfalls and lessons for the future.
Metharom P; Doyle B; Caplice NM
Nat Clin Pract Cardiovasc Med; 2007 Feb; 4 Suppl 1():S96-9. PubMed ID: 17230223
[TBL] [Abstract][Full Text] [Related]
4. Stem cell therapy for cardiac repair: benefits and barriers.
Joggerst SJ; Hatzopoulos AK
Expert Rev Mol Med; 2009 Jul; 11():e20. PubMed ID: 19586557
[TBL] [Abstract][Full Text] [Related]
5. [Stem cell therapy for cardiovascular diseases. Experiences in Düsseldorf].
Schannwell CM
Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 8():S274-9. PubMed ID: 19085806
[TBL] [Abstract][Full Text] [Related]
6. Frontiers in nephrology: the evolving therapeutic applications of endothelial progenitor cells.
Tongers J; Losordo DW
J Am Soc Nephrol; 2007 Nov; 18(11):2843-52. PubMed ID: 17942950
[TBL] [Abstract][Full Text] [Related]
7. [The therapeutic effect of autologous bone marrow cells in ischemic heart disease].
Hristov M; Keymel S; Weber C
Med Klin (Munich); 2006 Mar; 101 Suppl 1():186-9. PubMed ID: 16802551
[TBL] [Abstract][Full Text] [Related]
8. Bone-marrow-derived cells and heart repair.
Clavel C; Verfaillie CM
Curr Opin Organ Transplant; 2008 Feb; 13(1):36-43. PubMed ID: 18660705
[TBL] [Abstract][Full Text] [Related]
9. Progress and prospects: cell based regenerative therapy for cardiovascular disease.
de Muinck ED; Thompson C; Simons M
Gene Ther; 2006 Apr; 13(8):659-71. PubMed ID: 16319948
[TBL] [Abstract][Full Text] [Related]
10. Role of progenitor endothelial cells in cardiovascular disease and upcoming therapies.
Kawamoto A; Asahara T
Catheter Cardiovasc Interv; 2007 Oct; 70(4):477-84. PubMed ID: 17894361
[TBL] [Abstract][Full Text] [Related]
11. Myocardial regeneration induced by granulocyte-colony-stimulating factor mobilization of stem cells in patients with acute or chronic ischaemic heart disease: a non-invasive alternative for clinical stem cell therapy?
Kastrup J; Ripa RS; Wang Y; Jørgensen E
Eur Heart J; 2006 Dec; 27(23):2748-54. PubMed ID: 17065171
[TBL] [Abstract][Full Text] [Related]
12. The therapeutic potential of progenitor cells in ischemic heart disease--Past, present and future.
Hristov M; Weber C
Basic Res Cardiol; 2006 Jan; 101(1):1-7. PubMed ID: 16382288
[TBL] [Abstract][Full Text] [Related]
13. [Cardiovascular regenerative medicine at the crossroads. Clinical trials of cellular therapy must now be based on reliable experimental data from animals with characteristics similar to human's].
Nadal-Ginard B; Torella D; Ellison G
Rev Esp Cardiol; 2006 Nov; 59(11):1175-89. PubMed ID: 17144992
[TBL] [Abstract][Full Text] [Related]
14. Cell-enhancement strategies for the treatment of ischemic heart disease.
Seeger FH; Zeiher AM; Dimmeler S
Nat Clin Pract Cardiovasc Med; 2007 Feb; 4 Suppl 1():S110-3. PubMed ID: 17230207
[TBL] [Abstract][Full Text] [Related]
15. Autologous bone marrow stem cell therapy for the ischemic myocardium during coronary artery bypass grafting.
Yerebakan C; Kaminski A; Westphal B; Liebold A; Steinhoff G
Minim Invasive Ther Allied Technol; 2008; 17(2):143-8. PubMed ID: 18465448
[TBL] [Abstract][Full Text] [Related]
16. Bone marrow cell-mediated cardiovascular repair: potential of combined therapies.
Napoli C; Maione C; Schiano C; Fiorito C; Ignarro LJ
Trends Mol Med; 2007 Jul; 13(7):278-86. PubMed ID: 17574919
[TBL] [Abstract][Full Text] [Related]
17. Stem cells for cardiovascular repair - the challenges of the aging heart.
Ballard VL; Edelberg JM
J Mol Cell Cardiol; 2008 Oct; 45(4):582-92. PubMed ID: 18396293
[TBL] [Abstract][Full Text] [Related]
18. Endothelial progenitor cells in cell-based therapy for cardiovascular disease.
Rodriguez-Losada N; Garcia-Pinilla JM; Jimenez-Navarro MF; Gonzalez FJ
Cell Mol Biol (Noisy-le-grand); 2008 Oct; 54(1):11-23. PubMed ID: 18954547
[TBL] [Abstract][Full Text] [Related]
19. Myocardial-cell replacement: the science, the clinic and the future.
Caplice NM; Deb A
Nat Clin Pract Cardiovasc Med; 2004 Dec; 1(2):90-5. PubMed ID: 16265312
[TBL] [Abstract][Full Text] [Related]
20. [Stem cell therapy in ischemic heart disease].
Diederichsen AC; Møller JE; Kristiansen MA; Saekmose SG; Barington T; Videbaek LM; Kassem MS; Thayssen P
Ugeskr Laeger; 2006 Mar; 168(11):1111-4. PubMed ID: 16545213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
